CGON compared with DNTH: revenue, margins and what each company keeps, and the suppliers and customers both name

CGONCG Oncology, Inc.

Mkt capRevenueRevenue

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CGONCG Oncology, Inc.

DNTHDianthus Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

CGON, solidDNTH, dashed

Supply-chain overlap

Revenue flow

CGON: latest quarter is a loss; flow not drawable. DNTH: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CGON 0

None

Shared 0

No disclosed counterparties: CGON.

Only DNTH 3

—Nanjing Leads Biolabsunlistedsupplier

—IONTASunlistedsupplier

—Tenacia Biotechnology (Hong Kong)unlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CGONCG Oncology, Inc.

64.58▲+1.75%· post 64.65

Mkt cap$5.7BRevenue$1MQ2 FY26Revenue—

DNTHDianthus Therapeutics, Inc.

82.00▼−0.85%· post 82.00

ClosedOct 30 '26

Mkt cap$4.6BRevenue$761,000Q2 FY26Revenue$6MFY24

Compare

ClosedOct 30 '26

CGONCG Oncology, Inc.

DNTHDianthus Therapeutics, Inc.

64.58▲+1.75%post 64.65

Price

82.00▼−0.85%post 82.00

$5.7B

Mkt cap

$4.6B

Q2 FY26$1M

Revenue

$761,000Q2 FY26

—

Revenue

$6MFY24

CGON64.58▲+1.75%vsDNTH82.00▼−0.85%ClosedOct 30 '26